阿里拉姆制药

318.63
开盘价
323.03
市值
43.60B+
最高价
325.49
最低价
316.00
收盘价
NaN
成交量
360.70K+
市盈率
141.09
股息率
0.00%

阿里拉姆制药简介

Alnylam制药公司是一家全球商业阶段的生物制药公司,从事RNAi疗法的发现、开发和商业化。其产品包括ONPATTRO、GIVLAARI和OXLUMO。该公司由诺贝尔桂冠、大卫·巴特尔、托马斯·图希尔、菲利普·扎莫尔、保罗·R·施梅尔和菲利普·A·夏普于2002年6月14日创立,总部设在马萨诸塞州剑桥市。

如何购买 阿里拉姆制药 (ALNY)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 ALNY

购买 ALNY

通过 RockFlow App 或网页端搜索 ALNY,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.